Health Care: Drugs

Alkermes PLC (ALKS: NASDAQ)

$57.84 0.31 | 0.54%
07/21/17 - 10:36 AM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 745.69M 628.34M 618.79M 432.91M
Cost of Sales 132.12M 111.08M 135.90M 134.31M
Gross Operating Profit 613.57M 517.26M 482.89M 298.61M
Selling, General, and Administrative Expenses 374.13M 311.56M 199.91M 116.56M
Research & Development 387.15M 344.40M 272.04M 128.12M
Operating Income before D & A (EBITDA) -147.71M -138.71M 10.94M 53.92M
Depreciation & Amortization 60.96M 85.60M 98.09M 38.43M
Interest Income 3.75M 3.33M 1.97M 711.00K
Other Income - Net 5.42M 10.21M 84.57M -429.00K
Special Income / Charges n.a. 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -199.50M -210.76M -599.00K 15.78M
Interest Expense 14.89M 13.25M 13.43M 10.38M
Pre-Tax Income -214.39M -224.00M -14.03M 5.40M
Income Taxes -5.94M 3.16M 16.03M -12.25M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -208.44M -227.16M -30.06M 17.65M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -208.44M -227.16M -30.06M 17.65M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -208.44M -227.16M -30.06M 17.65M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
n.a. -227.16M -30.06M 17.65M
Preferred Dividends
Net Income Available To Common 0.00 -227.16M -30.06M 17.65M
Basic EPS from Continuing Ops. -1.38 -1.52 -0.21 0.13
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.38 -1.52 -0.21 0.13
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.38 -1.52 -0.21 0.13
Basic Normalized Net Income/Share n.a. -1.52 -0.21 0.13
EPS fr Continuing Ops. -1.38 -1.52 -0.21 0.12
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.38 -1.52 -0.21 0.12
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.38 -1.52 -0.21 0.12
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
n.a. -1.52 -0.21 0.12
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ALKS

Latest ALKS Headlines from TheStreet

More Financial News for ALKS

Press Releases for ALKS

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter